CD274 and cancer: Enhances or restores the immune system’s ability to recognize and eliminate cancer cells. Includes immune checkpoint inhibitors (e.g., anti-PD-1/PD-L1), CAR-T cells, and BiTEs. Helps reestablish immune surveillance [57,58].